相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Dendritic Cell-Based Immunotherapy for Prostate Cancer
Hanka Jaehnisch et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2010)
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer.
Philip W. Kantoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Integrated Data From 2 Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trials of Active Cellular Immunotherapy With Sipuleucel-T in Advanced Prostate Cancer
Celestia S. Higano et al.
CANCER (2009)
Review of clinical studies on dendritic cell-based vaccination of patients with malignant melanoma: assessment of correlation between clinical response and vaccine parameters
Lotte Engell-Noerregaard et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Vaccination strategies in patients with renal cell carcinoma
Anne Marie Asemissen et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Dendritic Cell Vaccination Combined with CTLA4 Blockade in Patients with Metastatic Melanoma
Antoni Ribas et al.
CLINICAL CANCER RESEARCH (2009)
Limited Amounts of Dendritic Cells Migrate into the T-Cell Area of Lymph Nodes but Have High Immune Activating Potential in Melanoma Patients
Pauline Verdijk et al.
CLINICAL CANCER RESEARCH (2009)
Clinical and Immunologic Effects of Intranodal Autologous Tumor Lysate-Dendritic Cell Vaccine with Aldesleukin (Interleukin 2) and IFN-α2a Therapy in Metastatic Renal Cell Carcinoma Patients
Thomas Schwaab et al.
CLINICAL CANCER RESEARCH (2009)
Improving the efficacy of cancer immunotherapy
J. Copier et al.
EUROPEAN JOURNAL OF CANCER (2009)
Vaccine Therapy in Patients with Renal Cell Carcinoma
Hein Van Poppel et al.
EUROPEAN UROLOGY (2009)
Massive expansion of regulatory T-cells following interleukin 2 treatment during a phase I-II dendritic cell-based immunotherapy of metastatic renal cancer
Francois M. Lemoine et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2009)
Imaging Surrogates of Tumor Response to Therapy: Anatomic and Functional Biomarkers
Binsheng Zhao et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
Advances in specific immunotherapy for prostate cancer
Andrea Kiessling et al.
EUROPEAN UROLOGY (2008)
Paradigm shifts in cancer vaccine therapy
Jeffrey Schlom et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2008)
Therapeutic dendritic cell vaccination of patients with metastatic renal cell carcinoma - A clinical, phase 1/2 trial
Annika Berntsen et al.
JOURNAL OF IMMUNOTHERAPY (2008)
Molecular origins of cancer - Cancer immunology
Olivera J. Finn
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Phase I/II study of immunotherapy using autologous tumor lysate-pulsed dendritic cells in patients with metastatic renal cell carcinoma
Jung Han Kim et al.
CLINICAL IMMUNOLOGY (2007)
Current approaches in dendritic cell generation and future implications for cancer immunotherapy
Sandra Tuyaerts et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Taking dendritic cells into medicine
Ralph M. Steinman et al.
NATURE (2007)
Immunotherapy with dendritic cells for prostate cancer
Anna-Katharina Thomas-Kaskel et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Immunotherapy of patients with hormone-refractory prostate carcinoma pre-treated with interferon-gamma and vaccinated with autologous PSA-peptide loaded dendritic cells -: A pilot study
B. Hildenbrand et al.
PROSTATE (2007)
Immunotherapy against metastatic renal cell carcinoma with mature dendritic cells
Akihiko Matsumoto et al.
INTERNATIONAL JOURNAL OF UROLOGY (2007)
Preliminary analysis of patients with progressive renal cell carcinoma vaccinated with CA9-peptide-pulsed mature dendritic cells
Ivar Bleumer et al.
JOURNAL OF IMMUNOTHERAPY (2007)
A clinical development paradigm for cancer vaccines and related biologics
Axel Hoos et al.
JOURNAL OF IMMUNOTHERAPY (2007)
Dendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinoma
Ying Waeckerle-Men et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
Vaccination of advanced prostate cancer patients with PSCA and PSA peptide-loaded dendritic cells induces DTH responses that correlate with superior overall survival
Anna-K. Thomas-Kaskell et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome
Jerom Galon et al.
SCIENCE (2006)
Induction of specific T cell immunity in patients with prostate cancer by vaccination with PSA146-154 peptide
Supriya Perambakam et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
Placebo-controlled phase III trial of immunologic therapy with sipuleucel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer
Eric J. Small et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Therapeutic dendritic cell vaccination of patients with renal cell carcinoma
A Berntsen et al.
EUROPEAN UROLOGY (2006)
Immunologic and clinical responses after vaccinations with peptide-pulsed dendritic cells in metastatic renal cancer patients
Jan Wierecky et al.
CANCER RESEARCH (2006)
Vaccination of hormone-refractory prostate cancer patients with peptide cocktail-loaded dendritic cells:: Results of a Phase I clinical trial
Susanne Fuessel et al.
PROSTATE (2006)
Clinical and immunologic responses to active specific cancer vaccines in human colorectal cancer
Dirk Nagorsen et al.
CLINICAL CANCER RESEARCH (2006)
Regulatory T cells, tumour immunity and immunotherapy
WP Zou
NATURE REVIEWS IMMUNOLOGY (2006)
CD40-activated B cells express full lymph node homing triad and induce T-cell chemotaxis: potential as cellular adjuvants
M von Bergwelt-Baildon et al.
BLOOD (2006)
Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells
J Dannull et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Immunotherapy with allotumour mRNA-transfected dendritic cells in androgen-resistant prostate cancer patients
LJ Mu et al.
BRITISH JOURNAL OF CANCER (2005)
Infiltration of activated dendritic cells and T cells in renal cell carcinoma following combined cytokine immunotherapy
N Verra et al.
EUROPEAN UROLOGY (2005)
Allogeneic dendritic cell vaccination against metastatic renal cell carcinoma with or without cyclophosphamide
L Höltl et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2005)
Telomerase mRNA-transfected dendritic cells stimulate antigen-specific CD8+ and CD4+ T cell responses in patients with metastatic prostate cancer
Z Su et al.
JOURNAL OF IMMUNOLOGY (2005)
Dendritic cell immunotherapy: mapping the way
CG Figdor et al.
NATURE MEDICINE (2004)
Clinical applications of dendritic cell vaccination in the treatment of cancer
DC Lee et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2004)
Adjuvant autologous renal tumour cell vaccine and risk of tumour progression in patients with renal-cell carcinoma after radical nephrectomy: phase III, randomised controlled trial
D Jocham et al.
LANCET (2004)
Cancer immunotherapy: moving beyond current vaccines
SA Rosenberg et al.
NATURE MEDICINE (2004)
Dendritic cell immunotherapy for urological cancers using cryopreserved allogeneic tumour lysate-pulsed cells: a phase I/II study
HS Pandha et al.
BJU INTERNATIONAL (2004)
Fusion cell vaccination of patients with metastatic breast and renal cancer induces immunological and clinical responses
D Avigan et al.
CLINICAL CANCER RESEARCH (2004)
Mechanisms and functional significance of tumour-induced dendritic-cell defects
D Gabrilovich
NATURE REVIEWS IMMUNOLOGY (2004)
Monitoring of CD4+ and CD8+ T-cell responses after dendritic cell-based immunotherapy using CFSE dye dilution analysis
T Putz et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2004)
Immune response induced in vitro by CD16(-) and CD16(+) monocyte-derived dendritic cells in patients with metastatic renal cell carcinoma treated with dendritic cell vaccines
JC Arroyo et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2004)
Vaccination of prostatectomized prostate cancer patients in biochemical relapse, with autologous dendritic cells pulsed with recombinant human PSA
B Barrou et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2004)
Lymphocyte trafficking across high endothelial venules: Dogmas and enigmas
M Miyasaka et al.
NATURE REVIEWS IMMUNOLOGY (2004)
A pilot trial of tumor lysate-loaded dendritic cells for the treatment of metastatic renal cell carcinoma
BJ Gitlitz et al.
JOURNAL OF IMMUNOTHERAPY (2003)
Regulation of dendritic cell migration to the draining lymph node:: Impact on T lymphocyte traffic and priming
A Martín-Fontecha et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Gene therapy to target dendritic cells from blood to lymph nodes
C Robert et al.
GENE THERAPY (2003)
Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo
A Wakkach et al.
IMMUNITY (2003)
Homing and cellular traffic in lymph nodes
UH von Andrian et al.
NATURE REVIEWS IMMUNOLOGY (2003)
Therapeutic vaccination against metastatic renal cell carcinoma by autologous dendritic cells:: preclinical results and outcome of a first clinical phase I/II trial
A Märten et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2002)
Vaccination of patients with metastatic renal cell carcinoma with autologous dendritic cells pulsed with autologous tumor antigens in combination with interleukin-2: A phase 1 study
JC Oosterwijk-Wakka et al.
JOURNAL OF IMMUNOTHERAPY (2002)
Cancer immunoediting: from immunosurveillance to tumor escape
GP Dunn et al.
NATURE IMMUNOLOGY (2002)
Avoiding horror autotoxicus: The importance of dendritic cells in peripheral T cell tolerance
RM Steinman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Dendritic cell-based xenoantigen vaccination for prostate cancer immunotherapy
L Fong et al.
JOURNAL OF IMMUNOLOGY (2001)
A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T-cell responses in humans following intranodal injection
H Jonuleit et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
Dendritic cells injected via different routes induce immunity in cancer patients
L Fong et al.
JOURNAL OF IMMUNOLOGY (2001)
Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells
MV Dhodapkar et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population
K Imai et al.
LANCET (2000)
分享论文
